A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet. (2019)
Attributed to:
MICA: The role of utrophin in DMD and its therapeutic potential
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpdd.642
PubMed Identifier: 30650257
Publication URI: http://europepmc.org/abstract/MED/30650257
Type: Journal Article/Review
Volume: 8
Parent Publication: Clinical pharmacology in drug development
Issue: 7
ISSN: 2160-763X